Skip to main page content

Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36-month Extension Results

My Session Status

Co:
Paper Presentation | Présentation d'article
Kiedy:
14:05, sobota 27 cze 2020 (10 min.)
Ścieżka:
Retina

My Session Status

Send Feedback